Welcome to the Division of Molecular Pathology!

Our division, based in the James Cancer Hospital and The Ohio State University Wexner Medical Center Department of Pathology, provides clinical molecular diagnostic testing for a wide range of cancer conditions, cardiovascular risk, and inheritable genetic disorders.

Our Mission:

To provide cutting edge, clinically responsible, high-quality and cost-effective diagnostic testing; be compassionately committed to care for every sample entrusted to us, serving the life behind the sample; and to educate students and clinical trainees in the practice of molecular pathology and genetics.

What We Do:

• Integrate genetic changes with standard microscopy to enhance diagnostics of cancer and inflammatory conditions
• Improve early detection of cancer and assist in selecting therapies based on genetic profile
• Deliver novel genomic assays for our institutional, academic, and industry partners
• Use advanced sequencing methods to link genetic changes with standard pathology workups in cancer diagnosis
• Deploy sensitive molecular methods to provide early diagnosis and post treatment monitoring of patients with cancer
• Advance pre-natal and pediatric genomic testing
• Develop companion diagnostics for targeted drug clinical trials in hematologic malignancies
• Offer COVID-19 genomic tests including SARS-CoV-2 sequencing and surveillance for viral genomic changes

Visit our Test Menu and Signature Assays pages to learn more!